Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 1/21/2025China's BMI Fund Reports Balanced Budget and Surplus for 2024
  • 1/21/2025ArriVent Enters Exclusive License with Lepu Biopharma for MRG007, an A...
  • 1/21/2025Sichuan Biokin Refiles for Hong Kong IPO Following Lapsed Application
  • 1/21/2025 China-based Ascentage Pharma Targets $149M in US IPO
  • 1/21/2025NiKang Does First Patient in a Phase 1b/2 Study of NKT2152 in Combo fo...
  • 1/21/2025CARsgen's Allogeneic CD38 CAR-T Therapy Administers First Dose in Inve...
  • 1/21/2025Zai Lab's NDA for Schizophrenia Treatment KarXT Accepted in China
  • 1/21/2025China to Solicit Feedbacks on Improving Centralized Drug Procurement ...
  • 1/21/2025Fermion and Simcere Join Forces to Develop Non-Opioid Analgesic 
  • 1/21/2025IVIEW Thera Completes Series A++ Financing to Advance Ophthalmology Pi...
  • 1/21/2025NMPA Approves Two Homegrown Oncology Therapies for Lung and Ovarian Ca...
  • 1/20/2025JOINN Biologics Acquires Lonza's Large Molecule CDMO Facility in Guang...
  • 1/20/2025NMPA Expands Label for Genrix Bio's Xeligekimab in Radiographic AS
  • 1/20/2025NMPA Expands Label for Kelun-Biotech's Tagitanlimab in First-Line NPC ...
  • 1/20/2025InnoCare and KeyMed Jointly Enter License Deal with Prolium for CD20xC...
  • 1/20/2025Junshi and LEO Enter Commercialization Partnership for Toripalimab in ...
  • 1/20/2025InflamaX Secures Pre-A Investment for Immuno-Inflammatory Research  
  • 1/17/2025Daiichi Sankyo Submits NDA for Pexidartinib (PLX3397) in China as the ...
  • 1/17/2025Simnova and Orna Expand Partnership to Include BCMA-Targeted RNA Thera...
  • 1/17/2025Bivision Secures ~CNY 100M in Series A+ Financing, Accelerates Targete...
  • 1/16/2025Hengrui Pharma Poised for Global Expansion, Eyes More Deals
  • 1/16/2025Menarini and Insilico Forge Strategic Partnership to Address Unmet Nee...
  • 1/16/2025Alphamab Advances Oncology Pipeline with Phase 2 Trial of TROP-2/HER3 ...
  • 1/16/2025Conjustar Biotech Completes CNY 100M Series Pre-A+ Financing
  • 1/16/2025NHSA Issues Notice on Advancing Real-Time Settlement Reform for BMI Fu...
  • 1/16/2025CDE Issues the Technical Guidelines for Clinical Risk Management Plans...
  • 1/15/2025U.S. Tightens Export Controls on Biotech Equipment Over AI and Securit...
  • 1/15/2025Luye Pharma Advances CNS Pipeline with Phase II Trial for LY03015 in C...
  • 1/15/2025Ucello Wins FDA IND Approval for Pioneering Allogeneic CAR-T Therapy
  • 1/15/2025Longen Therapeutics Secures Over CNY 100M in Pre-A Financing
  • Page:33/56 Total number of articles:1669: [First][<<] [31] [32] [33] [34] [35] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group